Skip to main content

Advertisement

Log in

Causes and consequences of 93 fetuses with cardiomegaly in a tertiary center in Thailand

  • Materno-fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objectives

To assess etiology, perinatal mortality and associated factors of fetal cardiomegaly (FC).

Methods

A retrospective study of fetuses with cardiomegaly was conducted. Demographic data, ultrasonographic findings, and outcomes were collected and analyzed.

Results

Ninety-three fetuses were analyzed. The causes of FC were cardiac causes 49.5%, Bart’s hemoglobinopathies 28%, and non-Bart’s anemia 15%. Ascites, pericardial effusion, and hydrops were more prevalent in fetuses with anemia than those with cardiac abnormalities. The overall perinatal mortality was 69.9%. Although all Bart’s hydrops died, perinatal mortality of non-Bart’s anemia, and structural cardiac defect were 57.1 and 69.7%, respectively. Excluding Bart’s anemia, receiver-operating characteristic curve analysis demonstrated that cardiothoracic ratio of ≥0.58 best predictive for perinatal mortality. Earlier gestational age at diagnosis, skin edema, and chromosomal abnormality were associated with higher mortality.

Conclusions

Majority causes of FC were cardiac and anemic in origin. It carried high-perinatal mortality depending on the causes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL (2006) A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 19:407–413

    Article  PubMed  Google Scholar 

  2. Huhta JC (2004) Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 25:274–286

    Article  PubMed  CAS  Google Scholar 

  3. Huhta JC (2005) Fetal congestive heart failure. Semin Fetal Neonatal Med 10:542–552

    Article  PubMed  Google Scholar 

  4. Kleinman CS, Donnerstein RL, DeVore GR, Jaffe CC, Lynch DC, Berkowitz RL et al (1982) Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med 306:568–575

    Article  PubMed  CAS  Google Scholar 

  5. Respondek M, Kaczmarek P, Pertynski T (1996) Fetal echocardiography guidelines to predict survival of fetuses with ascites. Ultrasound Obstet Gynecol 7:256–261

    Article  PubMed  CAS  Google Scholar 

  6. Chaoui R, Bollmann R, Goldner B, Heling KS, Tennstedt C (1994) Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther 9:92–104

    Article  PubMed  CAS  Google Scholar 

  7. Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15

    Article  PubMed  CAS  Google Scholar 

  8. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917

    Article  PubMed  CAS  Google Scholar 

  9. Leung KY, Liao C, Li QM et al (2006) A new strategy for prenatal diagnosis of homozygous alpha(α0)-thalassemia. Ultrasound Obstet Gynecol 28:173–177

    Article  PubMed  CAS  Google Scholar 

  10. von Kaisenberg CS, Jonat W (2001) Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 18:280–288

    Article  Google Scholar 

  11. Oyer CE, Ongcapin EH, Ni J, Bowles NE, Towbin JA (2000) Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction. Hum Pathol 31:1433–1435

    Article  PubMed  CAS  Google Scholar 

  12. Pedra SRFF, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R et al (2002) Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106:585–591

    Article  PubMed  Google Scholar 

  13. Sivasankaran S, Sharland GK, Simpson JM (2005) Dilated cardiomyopathy presenting during fetal life. Cardiol Young 15:409–416

    Article  PubMed  Google Scholar 

  14. Yinon Y, Yagel S, Hegesh J, Weisz B, Mazaki-Tovi S, Lipitz S et al (2007) Fetal cardiomyopathy-in utero evaluation and clinical significance. Prenat Diagn 27:23–28

    Article  PubMed  Google Scholar 

  15. Mari G, Adrignolo A, Abuhamad AZ, Pirhonen J, Jones DC, Ludomirsky A, Copel JA (1995) Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 5:400–405

    Article  PubMed  CAS  Google Scholar 

  16. Forestier F, Daffos F, Catherine N, Renard M, Andreux JP (1991) Developmental hematopoiesis in normal human fetal blood. Blood 77:2360–2363

    PubMed  CAS  Google Scholar 

  17. Nakayama R, Yamada D, Steinmiller V, Hsia E, Hale RW (1986) Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet Gynecol 67:176–180

    Article  PubMed  CAS  Google Scholar 

  18. Bolton-Maggs PHB, Stevens RJ, Dodd NJ, Lamont G, Tittensor P, King MJ (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. BJH 126:455–474

    Article  CAS  Google Scholar 

  19. Elchalal U, Ezra Y, Levi Y, Bar-oz B, Yanai N, Intrator O et al (2000) Sonographically thick placenta: a marker for increased perinatal risk—a prospective cross-sectional study. Placenta 21:268–272

    Article  PubMed  CAS  Google Scholar 

  20. Fyler DC, Buckley LP, Hellenbrand WE, Cohn HE (1980) Report of the New England Regional Infant Cardiac Program. Pediatrics 65:375–461

    Google Scholar 

  21. Gandhi JA, Zhang XY, Maidman JE (1995) Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol 173:1132–1136

    Article  PubMed  CAS  Google Scholar 

  22. Kush ML, Weiner CP, Harman CR, Baschat AA (2003) Lethal progression of a fetal intracranial arteriovenous malformation. J Ultrasound Med 22:645–648

    PubMed  Google Scholar 

  23. Skoll MA, Sharland GK, Allan LD (1991) Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol 1:309–312

    Article  PubMed  CAS  Google Scholar 

  24. Tennstedt C, Chaoui R, Korner H, Dietel M (1999) Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 82:34–39

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor Pornchai Sithisarankul, MD, MPH, DrPH. Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Associate Professor Apichai Khongphatthanayothin, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Professor Dr. Henry Wilde for their kind assistance in editing the manuscript and Dr. Mana Taweevisit, MD, Department of Pathology, Faculty of Medicine, Chulalongkorn University for his pathological reports.

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Boonchai Uerpairojkit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wuttikonsammakit, P., Uerpairojkit, B. & Tanawattanacharoen, S. Causes and consequences of 93 fetuses with cardiomegaly in a tertiary center in Thailand. Arch Gynecol Obstet 283, 701–706 (2011). https://doi.org/10.1007/s00404-010-1426-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1426-0

Keywords

Navigation